JEFFERY SHORT: Open Payments
NPI 1770568503 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,923 in 54 payments from 18 companies in 2025. Trend: 2023 $674 · 2024 $1,539 · 2025 $1,923
Food & beverage: $1,923
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $320 |
| Novo Nordisk Inc | 9 | $319 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $299 |
| Amgen Inc. | 10 | $206 |
| Phathom Pharmaceuticals, Inc. | 3 | $161 |
| Insulet Corporation | 2 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $94 |
| ABBVIE INC. | 4 | $87 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
Products named: Kerendia, Wegovy, VOQUEZNA, AIRSUPRA, REPATHA, OMNIPOD, BREZTRI, CAPLYTA.
Industry payments across NC — which companies pay providers there.
